Hypothyroidism
📧 Sign up to get email alerts when something new happens for Hypothyroidism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-04-20FDA Approved: LIOTHYRONINE SODIUM — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved the original ANDA for Liothyronine Sodium, a generic thyroid hormone replacement. The product is manufactured by Sun Pharmaceut…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Iodine Status of Preschoolers Given Micronutrient Powder for 6 Months [Phase 4]
Phase 4 clinical trial update on the iodine status of preschoolers after 6 months of micronutrient powder, with the study status reported as…
-
FDA label_change · 2015-11-25FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for SYNTHROID (levothyroxine sodium) submitted by AbbVie, resulting in a label change for the pr…
-
FDA approval · 2015-11-09FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Alvogen, Inc.)
FDA approved a Supplemental Application for Levothyroxine Sodium from Alvogen, Inc. to continue regulatory recognition of the drug under its…
-
CLINICAL_TRIALS trial_result · 2015-10-12Clinical Trial Update: Study of Optimal Replacement of Thyroxine in the Elderly [Phase 4]
Phase 4 clinical trial update on optimal thyroxine (levothyroxine) replacement in elderly patients with hypothyroidism; the study has comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-21Clinical Trial Update: Brown Adipose Tissue Activity and Thyroid Hormone [NA]
Completed clinical trial from Maastricht University Medical Center evaluating brown adipose tissue activity in relation to thyroid hormone i…
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test Formulation [Phase 2]
Phase 2 trial evaluating dose adjustment from levothyroxine to a new levothyroxine sodium test formulation has completed and reported result…
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
A completed clinical trial compared thyroid dysfunction between women with newly diagnosed breast cancer and healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Vitamin D, Iodine, and Lead Levels in Haitian Infants and Children.
Clinical Trial Update: Boston Children's Hospital completed a study evaluating vitamin D, iodine, and lead exposure in Haitian infants and c…
-
CLINICAL_TRIALS research · 2015-05-25Clinical Trial Update: The Prospective Study of Standard Treatment of Graves Disease Iodine 131 and Prevention of Adverse Reactions [Phase 3]
This entry covers an ongoing Phase 3 prospective trial of standard iodine-131 treatment for Graves' disease and prevention of adverse reacti…
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Osteopathy and Latent Hypothyroidism [NA]
An update on a clinical trial evaluating osteopathy for hypothyroidism; the current status of the study is unknown.
-
CLINICAL_TRIALS research · 2015-05-06Clinical Trial Update: Desiccated Thyroid Extract Versus Synthetic T3/T4 Combination (ThyrolarTM) Versus L-T4 Alone in the Therapy of Primary Hypothyroidism With Special Attention to the Gene Polymorphism [NA]
A clinical trial compares desiccated thyroid extract, a synthetic T3/T4 combination (Liotrix/Thyrolar), and L-T4 (levothyroxine) for primary…
-
FDA approval · 2015-04-15FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Synthroid (levothyroxine sodium) filed by AbbVie, indicating an approved change to the product's…
-
CLINICAL_TRIALS trial_result · 2015-03-18Clinical Trial Update: Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism
The document summarizes the completion of a clinical trial evaluating monitoring and evaluation of levothyroxine replacement therapy in preg…
-
FDA approval · 2015-02-09FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Lannett Company, Inc)
The FDA approved a supplemental application for LEVOTHYROXINE SODIUM from Lannett Company, Inc., updating or expanding the labeling for the …
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Detection of Celiac Disease in Patients With Hypothyroidism
A completed University of Vermont trial studied the detection of celiac disease in patients with hypothyroidism.
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Study to Verify Clinical Utility of Point-of-Care (POC) Thyroid Stimulating Hormone (TSH) Test Kits as Compared to Third Generation TSH Test Kit [Phase 4]
A Phase 4 clinical trial assessed the clinical utility of point-of-care TSH test kits versus a third-generation TSH test kit in hypothyroidi…
-
FDA approval · 2014-11-05FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
The FDA approved a supplemental application for LEVOXYL (levothyroxine sodium) from Pfizer Laboratories Div Pfizer Inc. This action updates …
-
FDA approval · 2014-10-30FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Levothyroxine Sodium from Mylan Pharmaceuticals Inc., approving changes to the existing product …
-
FDA approval · 2014-10-09FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental ANDA for levothyroxine sodium from Mylan Pharmaceuticals, authorizing the marketing of a generic levothyroxi…
-
FDA approval · 2014-09-09FDA Approved: LEVOTHYROXINE SODIUM — Supplemental Application (Amneal Pharmaceuticals NY LLC)
The FDA approved a supplemental application for levothyroxine sodium from Amneal Pharmaceuticals NY LLC.
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: A Study of T3 Therapy in Patients With Hypothyroidism [Phase 2]
Phase 2 study of T3 therapy for hypothyroidism has completed, according to the trial update. The document provides the trial status but does…
-
FDA approval · 2014-05-27FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Synthroid (levothyroxine sodium) from AbbVie, updating the product's labeling under NDA 021402.
-
FDA approval · 2014-05-06FDA Approved: LEVOXYL — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for LEVOXYL (levothyroxine sodium) submitted by Pfizer Laboratories Div Pfizer Inc. The action repre…
-
FDA approval · 2014-04-08FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Synthroid (levothyroxine sodium) from AbbVie, authorizing changes to the drug's labeling.